
ISASS: Use of rhBMP-2 and autologous bone in PLIF display similar clinical outcomes
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Synopsis
40 patients undergoing posterior lumbar interbody fusion (PLIF) were randomized to receive polyetheretherketone (PEEK) cages filled with either recombinant human bone morphogenic protein (rhBMP-2) or autologous bone to compare their clinical and radiological effects. At 24 months, the incidence of end plate resorption, osteolysis, and ectopic bone formation were frequently observed with rhBMP-2; h...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!

Join the Conversation
Please Login or Join to leave comments.